• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Synthesis and calcium channel blocker activity of alkyl 1,4-dihydro-2,6-dimethyl-4-nitrobenzyl thioimidazolyl-3,5-pyridinedicarboxylates.

作者信息

Zarghi A, Faizi M, Abdolahnejad R, Fassihi A

机构信息

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Shaheed Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Boll Chim Farm. 2003 May;142(4):175-9.

PMID:12918227
Abstract

New alkyl ester analogues of nifedipine, in which the orthonitrophenyl group of position 4 is replaced by 1-methyl 2-(p-nitrobenzyl)thio-5-imidazolyl substituent, were synthesized and evaluated as calcium-channel antagonists using the high K+ contraction of guinea-pig ileal longitudinal smooth muscle. The results for the symmetrical esters showed that increasing the length of methylen chain in C3 and C5 ester substituents decreased activity. When the presence of bulky lipophilic esters increased activity. In unsymmetrical diester series, the results showed when R1 is a small substituent (R1 = Me), increasing of the lipophilic property in R2 substituent increased the activity if this high lipophilicity don't accompany with steric hinderance. Our results demonstrate that the most active compound was diphenyl ester derivative and it was almost seven times more active than the reference drug nifedipine.

摘要

相似文献

1
Synthesis and calcium channel blocker activity of alkyl 1,4-dihydro-2,6-dimethyl-4-nitrobenzyl thioimidazolyl-3,5-pyridinedicarboxylates.
Boll Chim Farm. 2003 May;142(4):175-9.
2
Synthesis and calcium channel antagonist activity of nifedipine analogues containing 4(5)-chloro-2-methyl-5(4)-imidazolyl substituent.含4(5)-氯-2-甲基-5(4)-咪唑基取代基的硝苯地平类似物的合成及钙通道拮抗剂活性
Boll Chim Farm. 2001 Nov-Dec;140(6):381-6.
3
Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent.含4-(5)-氯-2-乙基-5-(4)-咪唑基取代基的新型1,4-二氢吡啶的设计、合成及钙通道拮抗剂活性
Arch Pharm (Weinheim). 2006 Jun;339(6):299-304. doi: 10.1002/ardp.200600013.
4
Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing dichloroimidazolyl substituents.含二氯咪唑基取代基的新型1,4 - 二氢吡啶衍生物的合成及钙通道拮抗剂活性
Arzneimittelforschung. 2002;52(1):21-6. doi: 10.1055/s-0031-1299851.
5
Synthesis and calcium channel antagonist activity of nifedipine analogues with methylthioimidazole substituent.具有甲硫基咪唑取代基的硝苯地平类似物的合成及钙通道拮抗剂活性
Farmaco. 2002 Mar;57(3):195-9. doi: 10.1016/s0014-827x(01)01191-0.
6
Synthesis and calcium antagonist activity of new 1,4-dihydropyridines containing nitrobenzylimidazolyl substituent in guinea-pig ileal smooth muscle.含硝基苄基咪唑基取代基的新型1,4 - 二氢吡啶在豚鼠回肠平滑肌中的合成及钙拮抗剂活性
Boll Chim Farm. 2002 Jan-Feb;141(1):15-20.
7
Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing lipophilic 4-imidazolyl substituents.含亲脂性4-咪唑基取代基的新型1,4-二氢吡啶衍生物的合成及其钙通道拮抗剂活性
Arzneimittelforschung. 2004;54(9):499-504. doi: 10.1055/s-0031-1297004.
8
Syntheses and calcium channel antagonist activity of nifedipine analogues with methylsulfonylimidazolyl substituent.
Pharm Acta Helv. 1998 Jul;73(2):75-9. doi: 10.1016/s0031-6865(98)00004-1.
9
Synthesis and calcium channel antagonist activity of nifedipine analogues containing 1-oxido-2-pyridyl in place of the 2-nitrophenyl moiety.含有1-氧化-2-吡啶基取代2-硝基苯基部分的硝苯地平类似物的合成及钙通道拮抗剂活性
Drug Des Deliv. 1988 Dec;3(4):337-41.
10
Design and synthesis of new 1,4-dihydropyridines containing 4(5)-chloro-5(4)-imidazolyl substituent as a novel calcium channel blocker.设计和合成含 4(5)-氯-5(4)-咪唑基取代基的新型 1,4-二氢吡啶类化合物作为新型钙通道阻滞剂。
Arch Pharm Res. 2011 Sep;34(9):1417-26. doi: 10.1007/s12272-011-0902-9. Epub 2011 Oct 6.